Compare AFLAC Incorporated (AFL) vs Johnson & Johnson (JNJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs Johnson & Johnson — how do they compare? AFLAC Incorporated trades at $121.41 (market cap $61.84B), while Johnson & Johnson trades at $263.18 (market cap $643.30B). The key difference: Johnson & Johnson is far larger — about 10.4× AFLAC Incorporated's market cap. Which is the better fit depends on your goals.
| AFL | JNJ | |
|---|---|---|
Market Cap | $61.84B | $643.30B |
Sector | Financials | Health |
52-Week High | $121.49 | $267.24 |
52-Week Low | $98.09 | $155.17 |
Enterprise Value | $70.50B | $676.24B |
Dividend Yield | 2.01% | 2.01% |
Volume | — | 6,156,228 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
